Baseline retinal testing is no longer recommended for hydroxychloroquine users in the United Kingdom. (2021)
Attributed to:
Development of AAV gene therapy for blindness caused by cone-rod dystrophy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keab141
PubMed Identifier: 33560336
Publication URI: http://europepmc.org/abstract/MED/33560336
Type: Journal Article/Review
Volume: 60
Parent Publication: Rheumatology (Oxford, England)
Issue: 5
ISSN: 1462-0324